iBio (IBIO) EBITDA Margin Growth (5y) (2016 - 2025)
iBio (IBIO) EBITDA Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -426,222.00 |
| Jun 30, 2025 | -233,748.00 |
| Dec 31, 2024 | -120,472.00 |
| Jun 30, 2024 | -143,819.00 |
| Sep 30, 2023 | -142,822.00 |
| Mar 31, 2022 | 1.03 Mn |
| Sep 30, 2021 | -388,394.00 |
| Jun 30, 2021 | -92,095.00 |
| Mar 31, 2021 | -13,101.00 |
| Dec 31, 2020 | 61,188.00 |
| Sep 30, 2020 | -55,566.00 |
| Jun 30, 2020 | 33,848.00 |
| Mar 31, 2020 | -374,967.00 |
| Dec 31, 2019 | -55,083.00 |
| Sep 30, 2019 | -339,655.00 |
| Jun 30, 2019 | 5,165.00 |
| Jun 30, 2018 | -412,524.00 |
| Sep 30, 2017 | -229,082.00 |
| Jun 30, 2017 | -201,374.00 |
| Mar 31, 2017 | -1.01 Mn |